MESO Jun 2024 6.000 call
| Previous close | 1.5000 |
| Open | 1.5000 |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 6.00 |
| Expiry date | 2024-06-21 |
| Day's range | 1.5000 - 1.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
Simply Wall St.High Insider Ownership Growth Stocks On The ASX In June 2024
Amidst a backdrop of geopolitical tensions impacting the Australian stock market, as evidenced by the slight downturn in ASX futures, investors continue to navigate through fluctuating global and domestic economic signals. In such an environment, stocks with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the company best—its leaders and key stakeholders.
Simply Wall St.Exploring Three ASX Growth Companies With Significant Insider Ownership
In the past year, the Australian market has shown a positive trajectory with an 8.2% increase, while remaining stable over the last seven days. In this context of expected annual earnings growth of 14%, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those who know the company best.
GlobeNewswireMesoblast Corporate Presentation at Investor Conference
NEW YORK, June 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference. Dr. Itescu reiterated that the Company expects to file this quarter the Biologics License Application (BLA) resubmission with the United States Food and Drug Administration (FDA) for its lead product candidate Ryoncil®(remestemcel-L) in the treatment of steroid-refractory acute graft versus host disease, wi
